US cancer care costs projected to rise sharply by 2020

US cancer care costs projected to rise sharply by 2020
Image: Intellect (generated)

In short: A modelling study projected how much the United States would spend on cancer care from 2010 to 2020, combining national cancer survival and incidence data with Medicare billing records. Assuming current rates of diagnosis, survival, and treatment costs stayed the same, the researchers estimated spending would rise from $124.57 billion in 2010 to $157.77 billion in 2020, a 27% increase driven mainly by a growing and aging population.

The steepest growth was projected in ongoing treatment for prostate and breast cancers, two of the most common long-term diagnoses. If treatment costs themselves rose by 2% a year rather than staying flat, the researchers estimated total spending could reach $173 billion by 2020, a 39% jump.

This is a modelling study built from historical Medicare and cancer registry data, not a measurement of actual future spending, so its projections depend on assumptions that may not hold.

Why it matters: Even without any change in how cancer is treated, US cancer care spending was projected to grow substantially simply because the population is growing and aging.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/wealth-research-aging-populations-are-driving-significant-increases-in-proje.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…